1,3-Dioxolane-2-propanoic acid, 2,4-dimethyl-, ethyl ester
Common Name: |
1,3-Dioxolane-2-propanoic acid, 2,4-dimethyl-, ethyl ester |
IUPAC Name: |
ethyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propanoate |
Molecular Formula: |
C10H18O4 |
SMILES: |
CCOC(=O)CCC1(OCC(O1)C)C |
Inchi: |
1S/C10H18O4/c1-4-12-9(11)5-6-10(3)13-7-8(2)14-10/h8H,4-7H2,1-3H3 |
Inchi Key: |
IAZAUEBWBHMDGV-UHFFFAOYSA-N |
Cas No: |
5413-49-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
202.25 |
Mass (g/mol) |
202.121 |
Molar Refractivity |
51.56 |
Net Charge |
|
HBD |
|
HBA |
4 |
Rt Bonds |
5 |
Rings |
1 |
TPSA |
44.76 |
Hetero Atoms |
4 |
Heavy Atoms |
14 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
240.00 to 245.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.038 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
1.481 |
iLOGP |
2.90 |
XLOGP3 |
1.03 |
WLOGP |
1.48 |
MLOGP |
0.86 |
ESOL Log S |
-1.41 |
ESOL Solubility (mg/ml) |
7.82 |
ESOL Solubility (mol/l) |
0.039 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.56 |
Ali Solubility (mg/ml) |
5.57 |
Ali Solubility (mol/l) |
0.03 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.02 |
Silicos-IT Solubility (mg/ml) |
1.93 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.80 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.376 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.983 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |